EUVIMEDEUVIMED entdecken
Crossref

Emergence of drug-resistant Elizabethkingia anophelis clinical isolates in Myanmar

Tatsuya Tada, Satoshi Oshiro, Naeko Mizutani, Koji Sato, Nang Sarm Hom, Pan Ei Soe, Thi Thi Htoon, Htay Htay Tin, Teruo Kirikae

Journal of Medical Microbiology · 2024

DOI: 10.1099/jmm.0.001917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2024. Verfasst von Tatsuya Tada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Flavobacteriaceae, Flavobacteriaceae Infections, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Seven drug-resistant Elizabethkingia anophelis isolates were obtained from inpatients in three medical settings in Myanmar between February 2017 and January 2021. All isolates were resistant to β-lactams and colistin. Among these, four isolates were resistant to amikacin with minimum inhibitory concentration (MIC) of ≥64 µg ml −1 . Six of the seven isolates harboured genes encoding intrinsic β-lactamases, including bla B , bla CME and bla GOB , whereas one isolate harboured bla B , bla CME and an incomplete bla GOB gene. Phylogenetic analysis based on whole-genome sequences revealed that several E. anophelis isolates in Myanmar formed their own clusters, whereas others were similar to isolates found in the USA. This is the first report of the emergence of Elizabethkingia species in Myanmar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavobacteriaceaeFlavobacteriaceae InfectionsAnti-Bacterial AgentsMicrobial Sensitivity TestsPhylogenyMyanmarHumansMalebeta-LactamasesDrug Resistance, Multiple, BacterialFemaleWhole Genome SequencingMiddle AgedAgedAdultColistin

Stichwörter der Autor:innen

Elizabethkingia anophelisFlavobacteriumcarbapenem resistance

Substanzen

Anti-Bacterial Agentsbeta-LactamasesColistin

Autor:innen und Institutionen

  • Department of Microbiology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
  • Juntendo Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan.
  • National Health Laboratory, Yangon, Myanmar.

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Tada, T., Oshiro, S., Mizutani, N., Sato, K., Hom, N. S., Soe, P. E., Htoon, T. T., Tin, H. H., & Kirikae, T. (2024). Emergence of drug-resistant Elizabethkingia anophelis clinical isolates in Myanmar. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001917

Vancouver

Tada T, Oshiro S, Mizutani N, Sato K, Hom NS, Soe PE, et al. Emergence of drug-resistant Elizabethkingia anophelis clinical isolates in Myanmar. Journal of Medical Microbiology. 2024. doi:10.1099/jmm.0.001917

BibTeX
@article{Tada2024,
  author = {Tada, Tatsuya and Oshiro, Satoshi and Mizutani, Naeko and Sato, Koji and Hom, Nang Sarm and Soe, Pan Ei and Htoon, Thi Thi and Tin, Htay Htay and Kirikae, Teruo},
  title = {Emergence of drug-resistant Elizabethkingia anophelis clinical isolates in Myanmar},
  journal = {Journal of Medical Microbiology},
  year = {2024},
  doi = {10.1099/jmm.0.001917}
}
Kostenlos starten →